Dutasteride Improves Outcomes of Benign Prostatic Hyperplasia When Evaluated for Prostate Cancer Risk Reduction: Secondary Analysis of the REduction by Dutasteride of Prostate Cancer Events (REDUCE) Trial

✍ Scribed by Claus G. Roehrborn; J. Curtis Nickel; Gerald L. Andriole; R. Paul Gagnier; Libby Black; Timothy H. Wilson; Roger S. Rittmaster

• Book ID: 116953599
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 686 KB
• Volume: 78
• Category: Article
• ISSN: 0090-4295
• DOI: 10.1016/j.urology.2011.03.063